Discover key insights from Basilea Pharmaceutica AG's Q4 2024 earnings call. Learn about robust revenue growth, FDA approvals, and pipeline advancements.

Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2024 financial results. Highlights ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Satyendar Jain had first moved the Rouse Avenue district court in May last year with a plea that the trial court proceedings, ...

Arch Capital Group Ltd. (NASDAQ:ACGL), a Bermuda-based insurer and reinsurer offering insurance, reinsurance, and mortgage insurance on a worldwide basis, has demonstrated resilience and adaptability ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

HighlightsSales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...

Aim-traded financial services group Tavistock Investments (TAVI:3.7p) transformed its finances last autumn by selling its financial advisory and estate planning businesses to private-equity-backed ...

Highlights Sales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...

Wynn Resorts, Limited (NASDAQ: WYNN) ("Wynn Resorts" or the "Company") today reported financial results for the fourth quarter ended December 31, 2024. Operating revenues were $1.84 billion for the ...

Revenues up 115% year-over-year to a record $1.01 billion.Q4 Net Deposits grow to a record $16 billion.Q4 Gold Subscribers up 86% ...